GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 3051 - 3100 of 39437 in total
PDB ID UniProt ID Title ▲ Descriptor
7RYN P01850 CD1a-sulfatide-gdTCR complex
7RYN A0A0C4DH28 CD1a-sulfatide-gdTCR complex
7RYN P01848 CD1a-sulfatide-gdTCR complex
7RYN A0A1B0GX56 CD1a-sulfatide-gdTCR complex
3OV6 P61769 CD1c in complex with MPM (mannosyl-beta1-phosphomycoketide) Beta-2-microglobulin, T-cell surface glycoprotein CD1c, T-cell surface glycoprotein CD1b
3OV6 P29016 CD1c in complex with MPM (mannosyl-beta1-phosphomycoketide) Beta-2-microglobulin, T-cell surface glycoprotein CD1c, T-cell surface glycoprotein CD1b
3OV6 P29017 CD1c in complex with MPM (mannosyl-beta1-phosphomycoketide) Beta-2-microglobulin, T-cell surface glycoprotein CD1c, T-cell surface glycoprotein CD1b
4ONO P61769 CD1c in complex with PM (phosphomycoketide) T-cell surface glycoprotein CD1c
4ONO P29016 CD1c in complex with PM (phosphomycoketide) T-cell surface glycoprotein CD1c
4ONO P29017 CD1c in complex with PM (phosphomycoketide) T-cell surface glycoprotein CD1c
6C15 P29017 CD1c in complex with phosphatidylcholine
6C15 P61769 CD1c in complex with phosphatidylcholine
7MX4 P29016 CD1c with antigen analogue 1
7MX4 P29017 CD1c with antigen analogue 1
7MX4 P61769 CD1c with antigen analogue 1
7MXF P29016 CD1c with antigen analogue 2
7MXF P29017 CD1c with antigen analogue 2
7MXF P61769 CD1c with antigen analogue 2
7MXH P29016 CD1c with antigen analogue 3
7MXH P29017 CD1c with antigen analogue 3
7MXH P61769 CD1c with antigen analogue 3
5VL3 S6B291 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 5VL3 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 S6B291 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 5VL3 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 Q8TCD0 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 Q8TCD0 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 P20273 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
7O52 7O52 CD22 d6-d7 in complex with Fab m971
6OPQ B3UES2 CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6OPQ B3UEZ6 CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6OPQ P01730 CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6OPQ 6OPQ CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6OPN B3UES2 CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 Envelope glycoprotein gp160, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4
6OPN B3UEZ6 CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 Envelope glycoprotein gp160, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4
6OPN P01730 CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 Envelope glycoprotein gp160, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4
5IWL 5IWL CD47-diabody complex 5F9 diabody, Leukocyte surface antigen CD47
5IWL Q08722 CD47-diabody complex 5F9 diabody, Leukocyte surface antigen CD47
6JMR P08195 CD98hc extracellular domain bound to HBJ127 Fab and MEM-108 Fab Antibody, 4F2 cell-surface antigen heavy chain
6JMR 6JMR CD98hc extracellular domain bound to HBJ127 Fab and MEM-108 Fab Antibody, 4F2 cell-surface antigen heavy chain
1QJW P07987 CEL6A (Y169F) WITH A NON-HYDROLYSABLE CELLOTETRAOSE CELLOBIOHYDROLASE CEL6A (FORMERLY CALLED CBH II) (E.C.3.2.1.91)
1HGW P07987 CEL6A D175A mutant
1HGY P07987 CEL6A D221A mutant
1QK0 P07987 CEL6A WITH A NON-HYDROLYSABLE CELLOTETRAOSE CELLOBIOHYDROLASE CEL6A (FORMERLY CALLED CBH II) (E.C.3.2.1.91)
1EGN P62694 CELLOBIOHYDROLASE CEL7A (E223S, A224H, L225V, T226A, D262G) MUTANT
1Q2B P62694 CELLOBIOHYDROLASE CEL7A WITH DISULPHIDE BRIDGE ADDED ACROSS EXO-LOOP BY MUTATIONS D241C AND D249C
1Q2E P00725 CELLOBIOHYDROLASE CEL7A WITH LOOP DELETION 245-252 AND BOUND NON-HYDROLYSABLE CELLOTETRAOSE EXOCELLOBIOHYDROLASE I (E.C.3.2.1.91)
5OA5 P62694 CELLOBIOHYDROLASE I (CEL7A) FROM HYPOCREA JECORINA WITH IMPROVED THERMAL STABILITY
6GRN P62694 CELLOBIOHYDROLASE I (CEL7A) FROM Trichoderma reesei with S-dihydroxypropranolol in the active site
1BVW Q9C1S9 CELLOBIOHYDROLASE II (CEL6A) FROM HUMICOLA INSOLENS

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024